Results 41 to 50 of about 4,469 (118)
Background: The United States Food and Drug Administration (US FDA) is responsible for ensuring public health by conducting a comprehensive assessment and approval of pharmaceuticals, medical devices, and food products.
Ajay Kumar Shukla, Saurav Misra
doaj +1 more source
Current status of radiation countermeasures for acute radiation syndrome under advanced development
The availability of safe and effective radiation countermeasures for the military and civilian population represents a significant unmet medical need. To expedite the development of countermeasures for life-threating situations, the United States Food ...
Vijay K Singh +6 more
doaj +1 more source
FDA and Its Role in Drug Development
JADPRO Live 2020 was honored to have Dr. Richard Pazdur, the Director of the Oncology Center of Excellence at the FDA, discuss recent changes to oncology drug development and the approval process, the roles of the advanced practitioner in the execution of clinical trials, and changes that have taken place as a result of the COVID-19 pandemic.
openaire +3 more sources
Background The low data publication rate for Food and Drug Administration (FDA)-approved drugs, and discrepancies between FDA-submitted versus published data, remain a concern. We investigated the publication statuses of sponsor-submitted clinical trials
Kenji Omae +6 more
doaj +1 more source
Introduction: Advancements in oncology have revolutionized cancer treatment, with new drugs being approved at different rates worldwide. Our objective was to evaluate the approval of new oncological drugs for solid tumors by the Food and Drug ...
Rafael Balsini Barreto +2 more
doaj +1 more source
Expanding regulatory science: Regulatory complementarity and reliance
Drug regulatory institutions, infrastructures, and systems are becoming increasingly interconnected across national boundaries and increasingly global in outlook. This process is reflected in the broadening and deepening application of the principles and
Jackson K. Mukonzo +5 more
doaj +1 more source
Publication of clinical trials supporting successful new drug applications: a literature analysis.
BackgroundThe United States (US) Food and Drug Administration (FDA) approves new drugs based on sponsor-submitted clinical trials. The publication status of these trials in the medical literature and factors associated with publication have not been ...
Kirby Lee, Peter Bacchetti, Ida Sim
doaj +1 more source
Bridging the new drug access gap between China and the United States and its related policies
Introduction: The access gap for novel pharmaceuticals between China and the developed countries is a major public health issue in China. It is crucial to understand the determinants of this gap to ensure timely access to new drugs and enhance patient ...
Xingyue Zhu, Yang Chen
doaj +1 more source
Pharmacogenomics (PGx) can facilitate the transition to patient-specific drug regimens and thus improve their efficacy and reduce toxicity. The aim of this study was to evaluate the overlap of PGx classification for drug absorption, distribution ...
Subrata Deb +3 more
doaj +1 more source
Tertiary Patents on Drugs Approved by the FDA
Importance Manufacturers of drug-device combinations, such as inhalers and injectable medications, often obtain patents not just on the active pharmaceutical ingredients of these products (primary patents) but also on other features, such as their formulations and methods of use (secondary patents) and delivery ...
Teng, Theodore W. +6 more
openaire +2 more sources

